A PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF STAGE 1 SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：311
|
作者：
DELGADO, G
BUNDY, BN
FOWLER, WC
STEHMAN, FB
SEVIN, B
CREASMAN, WT
MAJOR, F
DISAIA, P
ZAINO, R
机构：
[1] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[2] INDIANA UNIV,MED CTR,DEPT OBSTET & GYNECOL,GYNECOL ONCOL SECT,INDIANAPOLIS,IN 46202
[3] UNIV MIAMI,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,MIAMI,FL 33152
[4] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710
[5] UNIV COLORADO,HLTH SCI CTR,DEPT OBSTET & GYNECOL,DENVER,CO 80262
[6] DENVER GEN HOSP,GYNECOL TUMOR SERV,DENVER,CO 80204
[7] UNIV CALIF IRVINE,COLL MED,DEPT OBSTET & GYNECOL,IRVINE,CA 92717
[8] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT PATHOL,HERSHEY,PA 17033
[9] ROSWELL PK MEM INST,BUFFALO,NY
来源：
GYNECOLOGIC ONCOLOGY | 1989年 / 35卷 / 03期
关键词：
D O I：
10.1016/0090-8258(89)90070-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：314 / 320
页数：7
相关论文
共 50 条
  • [21] Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Muggia, FM
    Blessing, JA
    Method, M
    Miller, DS
    Johnson, GA
    Lee, RB
    Menzin, A
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 639 - 643
  • [22] Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
    Muggia, FM
    Blessing, JA
    McGehee, R
    Monk, BJ
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 483 - 487
  • [23] PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN PATIENTS WITH PREVIOUSLY-TREATED CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    ADCOCK, L
    WEBSTER, KD
    DEEULIS, T
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (04) : 341 - 343
  • [24] Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Moore, DH
    Blessing, JA
    McQuellon, RP
    Thaler, HT
    Cella, D
    Benda, J
    Miller, DS
    Olt, G
    King, S
    Boggess, JF
    Rocereto, TF
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3113 - 3119
  • [25] A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix a gynecologic oncology group study - A gynecologic oncology group study
    Malfetano, JH
    Blessing, JA
    Homesley, HD
    Look, KY
    McGehee, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (02): : 184 - 186
  • [26] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Steven C. Plaxe
    John A. Blessing
    George Olt
    Nader Husseinzadah
    Samuel S. Lentz
    Koen DeGeest
    Fidel A. Valea
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 151 - 154
  • [27] Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Rose, PG
    Blessing, JA
    Van Le, L
    Waggoner, S
    GYNECOLOGIC ONCOLOGY, 1998, 70 (02) : 263 - 266
  • [28] Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group
    Schilder, RJ
    Blessing, JA
    Morgan, M
    Mangan, CE
    Rader, JS
    GYNECOLOGIC ONCOLOGY, 2000, 76 (02) : 204 - 207
  • [29] Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A gynecologic oncology group study
    Bloss, JD
    Blessing, JA
    Behrens, BC
    Mannel, RS
    Rader, JS
    Sood, AK
    Markman, M
    Benda, J
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1832 - 1837
  • [30] A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
    Schilder, Russell J.
    Sill, Michael W.
    Lee, Yi-Chun
    Mannel, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 929 - 933
12345